API australian pharmaceutical industries limited

poor decision by management to withhold a dividend of any...

  1. 251 Posts.
    lightbulb Created with Sketch. 61
    poor decision by management to withhold a dividend of any sort.

    something stinks when a defensive stock like API , where demand for pharmaceuticals products is huge and interest rates at a low and individual earnings are being hit , API decides to withhold any form of dividend to assist its shareholders , some of whom are cash strapped.

    The results , whilst not as good as I expected , still supported at least a 2 cents dividend. given demand for it Pharma products would continue to be strong through autumn and winter , with or without Con19, and especially with Con19 .........see the decision of no dividend as despicable.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.